Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature. 2006;444(7119):638–42.
Henrard DR, Thornley AT, Brown ML, Rheinwald JG. Specific effects of ras oncogene expression on the growth and histogenesis of human epidermal keratinocytes. Oncogene. 1990;5(4):475–81.
Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 1997;88(5):593–602.
Article CAS PubMed Google Scholar
Michaloglou C, Vredeveld LCW, Soengas MS, Denoyelle C, Kuilman T, Van Der Horst CMAM, et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature. 2005;436(7051):720–4.
Article CAS PubMed Google Scholar
Miyauchi H, Minamino T, Tateno K, Kunieda T, Toko H, Komuro I. Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway. EMBO J. 2004;23(1):212–20.
Article CAS PubMed PubMed Central Google Scholar
Dimri GP, Itahana K, Acosta M, Campisi J. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14ARF tumor suppressor. Mol Cell Biol. 2000;20(1):273–85.
Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature. 2005;436(7051):725–30.
Article CAS PubMed PubMed Central Google Scholar
Courtois-Cox S, Jones SL, Cichowski K. Many roads lead to oncogene-induced senescence. Oncogene. 2008;27(20):2801–9.
Yaswen P, Campisi J. Oncogene-induced senescence pathways weave an intricate tapestry. Cell. 2007;128(2):233–4.
Article CAS PubMed Google Scholar
Campisi J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 2001;11(11):27–31.
Braig M, Schmitt CA. Oncogene-induced senescence: putting the brakes on tumor development. Cancer Res Cancer Res. 2006;66:2881–4.
Article CAS PubMed Google Scholar
Tateishi K, Ohta M, Kanai F, Guleng B, Tanaka Y, Asaoka Y, et al. Dysregulated expression of stem cell factor Bmi1 in precancerous lesions of the gastrointestinal tract. Clin Cancer Res. 2006;12(23):6960–6.
Article CAS PubMed Google Scholar
Gray-Schopfer VC, Cheong SC, Chong H, Chow J, Moss T, Abdel-Malek ZA, et al. Cellular senescence in naevi and immortalisation in melanoma: a role for p16? Br J Cancer. 2006;95(4):496–505.
Article CAS PubMed PubMed Central Google Scholar
Majumder PK, Grisanzio C, O’Connell F, Barry M, Brito JM, Xu Q, et al. A prostatic intraepithelial neoplasia-dependent p27 Kip1 checkpoint induces senescence and inhibits cell proliferation and cancer progression. Cancer Cell. 2008;14(2):146–55.
Article CAS PubMed PubMed Central Google Scholar
Bascones-Martínez A, López-Durán M, Cano-Sánchez J, Sánchez-Verde L, Díez-Rodríguez A, Aguirre-Echebarría P, et al. Differences in the expression of five senescence markers in oral cancer, oral leukoplakia and control samples in humans. Oncol Lett. 2012;3(6):1319–25.
Article PubMed PubMed Central Google Scholar
Kang TW, Yevsa T, Woller N, Hoenicke L, Wuestefeld T, Dauch D, et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature. 2011;479(7374):547–51.
Article CAS PubMed Google Scholar
Ritschka B, Storer M, Mas A, Heinzmann F, Ortells MC, Morton JP, et al. The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration. Genes Dev. 2017;31(2):172–83.
Article CAS PubMed PubMed Central Google Scholar
Acosta JC, Banito A, Wuestefeld T, Georgilis A, Janich P, Morton JP, et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol. 2013;15(8):978–90.
Article CAS PubMed PubMed Central Google Scholar
Malaquin N, Vercamer C, Bouali F, Martien S, Deruy E, Wernert N, et al. Senescent fibroblasts enhance early skin carcinogenic events via a paracrine MMP-PAR-1 Axis. Eckert RL, editor. PLoS ONE. 2013;8(5):e63607.
Article CAS PubMed PubMed Central Google Scholar
Martínez-Zamudio RI, Stefa A, Nabuco Leva Ferreira Freitas JA, Vasilopoulos T, Simpson M, Doré G, et al. Escape from oncogene-induced senescence is controlled by POU2F2 and memorized by chromatin scars. Cell Genomics. 2023;3(4):100293.
Article PubMed PubMed Central Google Scholar
Zhao Y, Wu Z, Chanal M, Guillaumond F, Goehrig D, Bachy S, et al. Oncogene-induced senescence limits the progression of pancreatic neoplasia through production of activin a. Cancer Res. 2020;80(16):3359–71.
Article CAS PubMed Google Scholar
Kolodkin-Gal D, Roitman L, Ovadya Y, Azazmeh N, Assouline B, Schlesinger Y, et al. Senolytic elimination of Cox2-expressing senescent cells inhibits the growth of premalignant pancreatic lesions. Gut. 2021;71(2):345–55.
Sarkisian CJ, Keister BA, Stairs DB, Boxer RB, Moody SE, Chodosh LA. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Nat Cell Biol. 2007;9(5):493–505.
Article CAS PubMed Google Scholar
Kennedy AL, Morton JP, Manoharan I, Nelson DM, Jamieson NB, Pawlikowski JS, et al. Activation of the PIK3CA/AKT pathway suppresses senescence induced by an activated RAS oncogene to promote tumorigenesis. Mol Cell. 2011;42(1):36–49.
Article CAS PubMed PubMed Central Google Scholar
Lee S, Yu Y, Trimpert J, Benthani F, Mairhofer M, Richter-Pechanska P, et al. Virus-induced senescence is a driver and therapeutic target in COVID-19. Nature. 2021;599(7884):283–9.
Article CAS PubMed Google Scholar
Litaker JR, Pan J, Cheung YC, Zhang DK, Liu Y, Wong SCH, et al. Expression profile of senescence-associated beta-galactosidase and activation of telomerase in human ovarian surface epithelial cells undergoing immortalization. Int J Oncol. 1998;13(5):951–6.
Filatov L, Golubovskaya V, Hurt JC, Byrd LL, Phillips JM, Kaufmann WK. Chromosomal instability is correlated with telomere erosion and inactivation of G2 checkpoint function in human fibroblasts expressing human papillomavirus type 16 E6 oncoprotein. Oncogene. 1998;16(14):1825–38.
Article CAS PubMed Google Scholar
Wells SI. Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21CIP-dependent pathways. EMBO J. 2000;19(21):5762–71.
Article CAS PubMed PubMed Central Google Scholar
Wells SI, Aronow BJ, Wise TM, Williams SS, Couget JA, Howley PM. Transcriptome signature of irreversible senescence in human papillomavirus-positive cervical cancer cells. Proc Natl Acad Sci U S A. 2003;100(12):7093–8.
Article CAS PubMed PubMed Central Google Scholar
Saleh T, Khasawneh AI, Himsawi N, Abu-Raideh J, Ejeilat V, Elshazly AM, et al. Senolytic therapy: a potential Approach for the elimination of Oncogene-Induced senescent HPV-Positive cells. Int J Mol Sci. 2022;23(24):15512.
Article CAS PubMed PubMed Central Google Scholar
Saleh T, Carpenter VJ. Potential use of senolytics for pharmacological targeting of precancerous lesions. Mol Pharmacol. 2021;100(6):580–7.
Linton KM, Hey Y, Dibben S, Miller CJ, Freemont AJ, Radford JA, et al. Methods comparison for high-resolution transcriptional analysis of archival material on Affymetrix Plus 2.0 and exon 1.0 microarrays. Biotechniques. 2009;47(1):587–96.
Article CAS PubMed Google Scholar
Regier N, Frey B. Experimental comparison of relative RT-qPCR quantification approaches for gene expression studies in poplar. BMC Mol Biol. 2010;11:57.
Comments (0)